Literature DB >> 11092754

Oa1 knock-out: new insights on the pathogenesis of ocular albinism type 1.

B Incerti1, K Cortese, A Pizzigoni, E M Surace, S Varani, M Coppola, G Jeffery, M Seeliger, G Jaissle, D C Bennett, V Marigo, M V Schiaffino, C Tacchetti, A Ballabio.   

Abstract

Ocular albinism type I (OA1) is an X-linked disorder characterized by severe reduction of visual acuity, strabismus, photophobia and nystagmus. Ophthalmologic examination reveals hypopigmentation of the retina, foveal hypoplasia and iris translucency. Microscopic examination of both retinal pigment epithelium (RPE) and skin melanocytes shows the presence of large pigment granules called giant melanosomes or macromelanosomes. In this study, we have generated and characterized Oa1-deficient mice by gene targeting (KO). The KO males are viable, fertile and phenotypically indistinguishable from the wild-type littermates. Ophthalmologic examination shows hypopigmentation of the ocular fundus in mutant animals compared with wild-type. Analysis of the retinofugal pathway reveals a reduction in the size of the uncrossed pathway, demonstrating a misrouting of the optic fibres at the chiasm, as observed in OA1 patients. Microscopic examination of the RPE shows the presence of giant melanosomes comparable with those described in OA1 patients. Ultrastructural analysis of the RPE cells, suggests that the giant melanosomes may form by abnormal growth of single melanosomes, rather than the fusion of several, shedding light on the pathogenesis of ocular albinism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11092754     DOI: 10.1093/hmg/9.19.2781

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  32 in total

1.  Structural insights into human GPCR protein OA1: a computational perspective.

Authors:  Anirban Ghosh; Uddhavesh Sonavane; Sai Krishna Andhirka; Gopala Krishna Aradhyam; Rajendra Joshi
Journal:  J Mol Model       Date:  2011-09-22       Impact factor: 1.810

Review 2.  Development of the retina and optic pathway.

Authors:  Benjamin E Reese
Journal:  Vision Res       Date:  2010-07-18       Impact factor: 1.886

Review 3.  The genetic and evolutionary basis of colour variation in vertebrates.

Authors:  Michael Hofreiter; Torsten Schöneberg
Journal:  Cell Mol Life Sci       Date:  2010-03-14       Impact factor: 9.261

4.  The ocular albinism type 1 (OA1) GPCR is ubiquitinated and its traffic requires endosomal sorting complex responsible for transport (ESCRT) function.

Authors:  Francesca Giordano; Sabrina Simoes; Graça Raposo
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

5.  The PIKfyve complex regulates the early melanosome homeostasis required for physiological amyloid formation.

Authors:  Christin Bissig; Pauline Croisé; Xavier Heiligenstein; Ilse Hurbain; Guy M Lenk; Emily Kaufman; Ragna Sannerud; Wim Annaert; Miriam H Meisler; Lois S Weisman; Graça Raposo; Guillaume van Niel
Journal:  J Cell Sci       Date:  2019-02-28       Impact factor: 5.285

Review 6.  Signaling pathways in melanosome biogenesis and pathology.

Authors:  Maria Vittoria Schiaffino
Journal:  Int J Biochem Cell Biol       Date:  2010-04-08       Impact factor: 5.085

7.  Deletion in the OA1 gene in a family with congenital X linked nystagmus.

Authors:  M Preising; J P Op de Laak; B Lorenz
Journal:  Br J Ophthalmol       Date:  2001-09       Impact factor: 4.638

8.  Anatomical profiling of G protein-coupled receptor expression.

Authors:  Jean B Regard; Isaac T Sato; Shaun R Coughlin
Journal:  Cell       Date:  2008-10-31       Impact factor: 41.582

9.  Modifying skin pigmentation - approaches through intrinsic biochemistry and exogenous agents.

Authors:  Michaela Brenner; Vincent J Hearing
Journal:  Drug Discov Today Dis Mech       Date:  2008

10.  Retinal pigment epithelial integrity is compromised in the developing albino mouse retina.

Authors:  Lena Iwai-Takekoshi; Anna Ramos; Ari Schaler; Samuel Weinreb; Richard Blazeski; Carol Mason
Journal:  J Comp Neurol       Date:  2016-05-19       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.